annual CFO:
-$36.98M+$10.04M(+21.36%)Summary
- As of today (September 16, 2025), XERS annual cash flow from operations is -$36.98 million, with the most recent change of +$10.04 million (+21.36%) on December 31, 2024.
- During the last 3 years, XERS annual CFO has risen by +$58.55 million (+61.29%).
- XERS annual CFO is now -129.88% below its all-time high of -$16.09 million, reached on December 31, 2016.
Performance
XERS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$182.00K+$10.21M(+101.81%)Summary
- As of today (September 16, 2025), XERS quarterly cash flow from operations is $182.00 thousand, with the most recent change of +$10.21 million (+101.81%) on June 30, 2025.
- Over the past year, XERS quarterly CFO has increased by +$10.53 million (+101.76%).
- XERS quarterly CFO is now -97.56% below its all-time high of $7.47 million, reached on December 31, 2023.
Performance
XERS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$16.18M+$10.53M(+39.42%)Summary
- As of today (September 16, 2025), XERS TTM cash flow from operations is -$16.18 million, with the most recent change of +$10.53 million (+39.42%) on June 30, 2025.
- Over the past year, XERS TTM CFO has increased by +$21.61 million (+57.19%).
- XERS TTM CFO is now -359.76% below its all-time high of -$3.52 million, reached on March 31, 2017.
Performance
XERS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
XERS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.4% | +101.8% | +57.2% |
| 3 y3 years | +61.3% | +100.9% | +86.6% |
| 5 y5 years | +64.6% | +100.8% | +85.7% |
XERS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.1% | -97.6% | +100.7% | at high | +86.6% |
| 5 y | 5-year | at high | +64.6% | -97.6% | +100.4% | at high | +86.6% |
| alltime | all time | -129.9% | +64.6% | -97.6% | +100.4% | -359.8% | +86.6% |
XERS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $182.00K(-101.8%) | -$16.18M(-39.4%) |
| Mar 2025 | - | -$10.03M(-607.9%) | -$26.71M(-27.8%) |
| Dec 2024 | -$36.98M(-21.4%) | $1.98M(-123.8%) | -$36.98M(+17.5%) |
| Sep 2024 | - | -$8.30M(-19.7%) | -$31.48M(-16.7%) |
| Jun 2024 | - | -$10.35M(-49.0%) | -$37.79M(-8.2%) |
| Mar 2024 | - | -$20.30M(-371.8%) | -$41.19M(-12.4%) |
| Dec 2023 | -$47.02M(-54.3%) | $7.47M(-151.1%) | -$47.02M(-33.4%) |
| Sep 2023 | - | -$14.61M(+6.3%) | -$70.61M(-4.3%) |
| Jun 2023 | - | -$13.74M(-47.4%) | -$73.76M(-8.5%) |
| Mar 2023 | - | -$26.14M(+62.2%) | -$80.62M(-21.6%) |
| Dec 2022 | -$102.89M(+7.7%) | -$16.12M(-9.2%) | -$102.89M(-11.1%) |
| Sep 2022 | - | -$17.75M(-13.9%) | -$115.72M(-4.0%) |
| Jun 2022 | - | -$20.61M(-57.4%) | -$120.58M(+0.5%) |
| Mar 2022 | - | -$48.41M(+67.2%) | -$119.99M(+25.6%) |
| Dec 2021 | -$95.53M | -$28.95M(+28.0%) | -$95.53M(+23.3%) |
| Sep 2021 | - | -$22.61M(+12.9%) | -$77.46M(+7.8%) |
| Jun 2021 | - | -$20.02M(-16.4%) | -$71.83M(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$23.96M(+120.4%) | -$75.57M(-6.2%) |
| Dec 2020 | -$80.56M(-22.8%) | -$10.87M(-36.0%) | -$80.56M(-18.8%) |
| Sep 2020 | - | -$16.98M(-28.5%) | -$99.26M(-12.0%) |
| Jun 2020 | - | -$23.76M(-17.9%) | -$112.86M(+0.6%) |
| Mar 2020 | - | -$28.95M(-2.1%) | -$112.14M(+7.5%) |
| Dec 2019 | -$104.35M(+85.4%) | -$29.57M(-3.3%) | -$104.35M(+12.1%) |
| Sep 2019 | - | -$30.58M(+32.8%) | -$93.11M(+18.7%) |
| Jun 2019 | - | -$23.04M(+8.9%) | -$78.44M(+12.7%) |
| Mar 2019 | - | -$21.15M(+15.4%) | -$69.63M(+23.7%) |
| Dec 2018 | -$56.28M(+128.2%) | -$18.34M(+15.2%) | -$56.28M(+19.6%) |
| Sep 2018 | - | -$15.92M(+11.9%) | -$47.04M(+28.2%) |
| Jun 2018 | - | -$14.22M(+82.2%) | -$36.70M(+63.3%) |
| Mar 2018 | - | -$7.80M(-14.2%) | -$22.48M(+23.6%) |
| Dec 2017 | -$24.66M(+53.3%) | -$9.10M(+63.2%) | -$18.20M(+100.0%) |
| Sep 2017 | - | -$5.58M(+58.5%) | -$9.10M(+158.5%) |
| Mar 2017 | - | -$3.52M | -$3.52M |
| Dec 2016 | -$16.09M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual CFO year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly CFO year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM CFO year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual cash flow from operations?
The current annual CFO of XERS is -$36.98M
What is the all time high annual CFO for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual cash flow from operations is -$16.09M
What is Xeris Biopharma Holdings, Inc. annual CFO year-on-year change?
Over the past year, XERS annual cash flow from operations has changed by +$10.04M (+21.36%)
What is Xeris Biopharma Holdings, Inc. quarterly cash flow from operations?
The current quarterly CFO of XERS is $182.00K
What is the all time high quarterly CFO for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly cash flow from operations is $7.47M
What is Xeris Biopharma Holdings, Inc. quarterly CFO year-on-year change?
Over the past year, XERS quarterly cash flow from operations has changed by +$10.53M (+101.76%)
What is Xeris Biopharma Holdings, Inc. TTM cash flow from operations?
The current TTM CFO of XERS is -$16.18M
What is the all time high TTM CFO for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM cash flow from operations is -$3.52M
What is Xeris Biopharma Holdings, Inc. TTM CFO year-on-year change?
Over the past year, XERS TTM cash flow from operations has changed by +$21.61M (+57.19%)